IMU Biosciences utilizes systems-level immunophenotyping and machine learning analytics to map the immune system, generating over 2,000 discrete cell subset profiles. This technology enables precise disease modeling and drug development, facilitating advancements in personalized immune medicine.
Funding
$15.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for analyzing the immune system often lack the depth and scale needed to fully understand its complexity. This limitation hinders the development of effective, personalized treatments for immune-related diseases. Traditional approaches struggle to translate vast amounts of immune data into actionable insights for drug discovery and patient care.
Solution
IMU Biosciences offers a multi-omic discovery platform that decodes the immune system at a systems level, providing unprecedented insights into immune-related diseases. The platform utilizes high-resolution immunophenotyping and advanced AI/ML analytics to measure over 2,000 discrete cell subsets, capturing comprehensive immune profiles. By generating, harmonizing, and translating vast system-level immune data, IMU enables in-depth disease modeling, drug development, patient monitoring, and translational research. This approach facilitates the discovery of clinically actionable immune signatures, increases the success rate of drug development, and ultimately delivers immune-driven precision medicine.
Target Audience
IMU Biosciences primarily serves pharmaceutical companies, research organizations, and academic institutions involved in translational research and precision drug development.
Features
- Multi-omic, high-resolution immune profiling for detailed immune system analysis
- AI-powered analytics to translate complex immune data into actionable insights
- Population-scale data analysis for comprehensive understanding of immune responses
- Identification of clinically actionable, systems-level immune signatures
- Support for precision approaches in diagnosing, monitoring, and treating diseases
- Tools to increase success in drug discovery and development